The obesity drugs that powered huge investor gains in 2023 are poised to inspire more corporate dealmaking, scientific breakthroughs and better patient.
Shares of Amgen Inc. gained 1.1% premarket on Tuesday after BMO Capital Markets analysts upgraded the stock to outperform, from market perform, citing the.
Structure Therapeutics Inc. American depositary receipts dropped 40% premarket on Monday after the company released new data from a study of GSBR-1290, its.